Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Catherine A. Vicary"'
Autor:
Marc Rubin, Eugene R. Schiff, Catherine A. Vicary, Robert P. Perrillo, Maria Bartholomew, Jules L. Dienstag
Publikováno v:
New England Journal of Medicine. 333:1657-1661
Better treatments for chronic hepatitis B are needed. Lamivudine, the (-)enantiomer of 3'-thiacytidine, is a potent inhibitor of hepatitis B virus (HBV).In a double-blind trial, we randomly assigned 32 patients with chronic hepatitis B (including 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a57324480b37b2b66d43dd767164a2b
https://doi.org/10.1056/nejm199512213332501
https://doi.org/10.1056/nejm199512213332501
Autor:
Catherine A. Vicary, Steven N. Warthan, James M. Pluda, John Ruedy, Timothy P. Cooley, Nancy E. Reinhalter, Julio S. G. Montaner, Robert Yarchoan, Mark A. Wainberg, Joseph B. Quinn, Laura E. Shay, Hilary M. Hirst, Marc Rubin, Geoffrey J. Yuen
Publikováno v:
Journal of Infectious Diseases. 171:1438-1447
In a phase I/II trial assessing the toxicity, pharmacokinetics, and activity of the (-)enantiomer of 2'-deoxy-3'-thiacytidine (3TC, lamivudine), 97 patients with AIDS or advanced human immunodeficiency virus (HIV) disease were administered 3TC at 0.5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7db46ba8ad260e85d3e389f2061c9dcd
https://doi.org/10.1093/infdis/171.6.1438
https://doi.org/10.1093/infdis/171.6.1438
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 6:73-76
Acyclovir levels to date have been performed on plasma rather than serum samples. To determine if serum was an acceptable specimen, acyclovir levels were measured on simultaneously collected plasma and serum samples by radioimmunoassay. Eighty-two pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::093458c00a0641e837ef87a41092bd95
https://doi.org/10.1016/0732-8893(87)90117-9
https://doi.org/10.1016/0732-8893(87)90117-9
Autor:
John H. Kersey, Joel D. Meyers, Paula S. Dandliker, David H. Shepp, E. Donnall Thomas, Elizabeth C. Reed, Catherine A. Vicary, L. E. Kirk, Nancy Flournoy, Henry H. Balfour, Mark D. Thornquist
Publikováno v:
New England Journal of Medicine. 318:70-75
Patients undergoing allogeneic bone marrow transplantation who are seropositive for cytomegalovirus are vulnerable to serious cytomegalovirus infection, presumably because of reactivation of latent endogenous virus and severe immunosuppression. We ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78934b9ca9bb8212d9a6675a97bd03e3
https://doi.org/10.1056/nejm198801143180202
https://doi.org/10.1056/nejm198801143180202